Skip to main content

Table 2 Disease-free survival analysis by Cox regression in TCGA patients

From: A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97

DFS Multivariable analysis
HR 95% CI for HR p value
mir152
 mir152 expression levela 0.228 0.072–0.722 0.012
 Age 0.999 0.970–1.028 0.928
 Gleason Scoreb
  6    < 0.0001
  7 5.528 0.754–40.536 0.093
  8 11.104 1.455–84.709 0.020
  9 23.559 3.247–170.946 0.002
  10 24.146 1.502–388.242 0.025
TMEM97
TMEM97 expression levela 1.007 0.550–1844 0.980
 Age 1.000 0.971–1.029 0.978
 Gleason Scoreb
  6    < 0.0001
  7 5.369 0.732–39.373 0.098
  8 10.978 1.438–83.790 0.002
  9 23.087 3.179–167.641 0.005
  10 30.812 2.786–340.785 0.978
NOL4
NOL4 expression levela 0.778 0.392–1.545 0.473
 Age 1.000 0.972–1.029 0.979
 Gleason Scoreb
  6    < 0.0001
  7 5.309 0.724–38.935 0.101
  8 10.967 1.438–83.629 0.021
  9 22.911 3.158–166.213 0.002
  10 31.102 2.811–344.117 0.005
  1. p value significant when p < 0.05
  2. HR hazard ratio, CI confidence interval.
  3. aReference group: high expression level
  4. bReference group: Gleason Score 6